Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

The genetic basis of Fabry disease

In: Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 33.
Affiliations
Free Books & Documents
Review

The genetic basis of Fabry disease

Andreas Gal et al.
Free Books & Documents

Excerpt

The coding region of the α-galactosidase A gene (GLA) consists of 1290 base pairs, is divided into seven exons and defines a polypeptide of 429 amino acids. The great majority of disease-related GLA mutations are unique ('private'). We have compiled a list of 429 mutations of the GLA gene from the published literature, including 306 point mutations (missense, nonsense and those affecting splice sites), 115 'short-length' rearrangements (affecting fewer than 60 nucleotides) and eight gross rearrangements (affecting one or more exons). Based on the number of different changes at any nucleotide position, there is no obvious 'hot spot' for point mutations, although mutations of CpG dinucleotides account for the majority of recurrent point mutations seen in unrelated families with Fabry disease. Remarkably, about one-third of the short-length rearrangements occur in exon 7, which accounts for only 22% of the coding region, suggesting that this part of the gene is susceptible to rearrangement. The recent elaboration of a putative three-dimensional structure of α-galactosidase A by X-ray crystallography may provide a better insight into how the enzyme works at the molecular level. This knowledge has recently been used for computer modelling of the structure of α-galactosidase A mutants and may result in improved understanding of the molecular pathology of the mutated protein. It is hoped that an increased understanding of structure/function correlates will help to develop alternative therapies or adjuvant treatments for Fabry disease.

PubMed Disclaimer

References

    1. Yasuda M, Shabbeer J, Benson SD, Maire I, Burnett RM, Desnick RJ. Fabry disease: characterization of α-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele. Hum Mutat. 2003;22:486–92. - PubMed
    1. Ishii S, Sakuraba H, Suzuki Y. Point mutations in the upstream region of the α-galactosidase A gene exon 6 in an atypical variant of Fabry disease. Hum Genet. 1992;89:29–32. - PubMed
    1. Altarescu GM, Goldfarb LG, Park KY, Kaneski C, Jeffries N, Litvak S et al. Identification of fifteen novel mutations and genotype–phenotype relationship in Fabry disease. Clin Genet. 2001;60:46–51. - PubMed
    1. Schaefer E, Mehta A, Gal A. Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey. Acta Paediatr Suppl. 2005;94:87–92. 79. - PubMed
    1. Blanch LC, Meaney C, Morris CP. A sensitive mutation screening strategy for Fabry disease: detection of nine mutations in the α-galactosidase A gene. Hum Mutat. 1996;8:38–43. - PubMed

LinkOut - more resources